Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services
- PMID: 28297075
- PMCID: PMC5346490
- DOI: 10.1111/1475-6773.12539
Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services
Abstract
Objective: To learn if a quality of care Medicaid child psychiatric consultation service implemented in three different steps was linked to changes in statewide child antipsychotic utilization.
Data sources/study setting: Washington State child psychiatry consultation program primary data and Medicaid pharmacy division antipsychotic utilization secondary data from July 1, 2006, through December 31, 2013.
Study design: Observational study in which consult program data were analyzed with a time series analysis of statewide antipsychotic utilization.
Data collection/extraction methods: All consultation program database information involving antipsychotics was compared to Medicaid pharmacy division database information involving antipsychotic utilization.
Principal findings: Washington State's total child Medicaid antipsychotic utilization fell from 0.51 to 0.25 percent. The monthly prevalence of use fell by a mean of 0.022 per thousand per month following the initiation of elective consults (p = .004), by 0.065 following the initiation of age/dose triggered mandatory reviews (p < .001), then by another 0.022 following the initiation of two or more concurrent antipsychotic mandatory reviews (p = .001). High-dose antipsychotic use fell by 57.8 percent in children 6- to 12-year old and fell by 52.1 percent in teens.
Conclusions: Statewide antipsychotic prescribing for Medicaid clients fell significantly at different rates following each implementation step of a multilevel consultation and best-practice education service.
Keywords: Antipsychotic agents; Medicaid; child and adolescent psychiatry; outcome assessment (health care); referral and consultation.
© Health Research and Educational Trust.
Figures


Note. *Shaded bar represents 9‐month period from start of reviews until change in use of antipsychotic at dose > maximum allowed stabilized.
Similar articles
-
Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.Psychiatr Serv. 2017 Oct 1;68(10):1061-1067. doi: 10.1176/appi.ps.201600489. Epub 2017 Jun 1. Psychiatr Serv. 2017. PMID: 28566023
-
Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.J Am Acad Child Adolesc Psychiatry. 2017 Jan;56(1):59-66. doi: 10.1016/j.jaac.2016.10.005. Epub 2016 Oct 24. J Am Acad Child Adolesc Psychiatry. 2017. PMID: 27993230
-
The Partnership Access Line: evaluating a child psychiatry consult program in Washington State.JAMA Pediatr. 2013 Feb;167(2):162-8. doi: 10.1001/2013.jamapediatrics.47. JAMA Pediatr. 2013. PMID: 23247331
-
A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents.Can J Psychiatry. 2012 Dec;57(12):717-21. doi: 10.1177/070674371205701202. Can J Psychiatry. 2012. PMID: 23228229 Review.
-
Use of antipsychotic medications in pediatric populations: what do the data say?Curr Psychiatry Rep. 2013 Dec;15(12):426. doi: 10.1007/s11920-013-0426-8. Curr Psychiatry Rep. 2013. PMID: 24258527 Free PMC article. Review.
Cited by
-
The Family is the Patient: Promoting Early Childhood Mental Health in Pediatric Care.Pediatrics. 2022 May 1;149(Suppl 5):e2021053509L. doi: 10.1542/peds.2021-053509L. Pediatrics. 2022. PMID: 35503309 Free PMC article.
-
Evaluation of the Safer Use of Antipsychotics in Youth Study on Population Level Antipsychotic Initiation: An Interrupted Time Series Analysis.J Child Adolesc Psychopharmacol. 2024 Sep;34(7):310-318. doi: 10.1089/cap.2024.0007. Epub 2024 May 14. J Child Adolesc Psychopharmacol. 2024. PMID: 38743639
-
Cost of Implementing an Evidence-Based Intervention to Support Safer Use of Antipsychotics in Youth.Adm Policy Ment Health. 2023 Sep;50(5):725-733. doi: 10.1007/s10488-023-01273-y. Epub 2023 Jun 1. Adm Policy Ment Health. 2023. PMID: 37261566
-
Systematic Review: Child Psychiatry Access Program Outcomes.JAACAP Open. 2023 Nov;1(3):154-172. doi: 10.1016/j.jaacop.2023.07.003. Epub 2023 Aug 1. JAACAP Open. 2023. PMID: 38189028 Free PMC article.
-
Effectiveness of mandatory peer review to reduce antipsychotic prescriptions for Medicaid-insured children.Health Serv Res. 2020 Aug;55(4):596-603. doi: 10.1111/1475-6773.13297. Epub 2020 Jun 21. Health Serv Res. 2020. PMID: 32567089 Free PMC article.
References
-
- “Achieving the Promise: Transforming Mental Health Care in America.” 2013. President's New Freedom Commission on Mental Health; Published July [accessed on December 16, 2015]. Available at http://govinfo.library.unt.edu/mentalhealthcommission/reports/FinalRepor...
-
- Andrade, S. E. , Lo J. C., Roblin D., and Fouayzi H.. 2011. “Antipsychotic Medication Use among Children and Risk of Diabetes Mellitus.” Pediatrics 128 (6): 1135–41. - PubMed
-
- Burcu, M. , Zito J. M., Ibe A., and Safer D.. 2014. “Atypical Antipsychotic Use Among Medicaid‐Insured Children and Adolescents: Duration, Safety, and Monitoring Implications.” Journal of Child and Adolescent Psychopharmacology 24 (3): 112–9. - PubMed
-
- Child and Family Service Improvement and Innovation Act . 2011. (P.L. 112‐34). [accessed on May 7, 2015]. Available at http://www.gpo.gov/fdsys/pkg/PLAW-112publ34/content-detail.html
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical